Escalation and De-escalation of Temporary Mechanical Circulatory Support: Joint Consensus Report of the PeriOperative Quality Initiative and the Enhanced Recovery After Surgery Cardiac Society.

Ann Thorac Surg

Division of Cardiothoracic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas; Department of Cardiovascular Surgery, Texas Heart Institute, Houston, Texas; Division of Acute Care Surgery/Trauma, Michael E. DeBakey Department of Surgery, Baylor College of Me

Published: August 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Temporary mechanical circulatory support (tMCS) for cardiogenic shock (CS) is increasing despite knowledge gaps and variations in management practices. This document was created to provide clinicians with guidance regarding initiation, escalation, and de-escalation of tMCS in patients with CS.

Methods: An interdisciplinary, international expert panel using a structured literature appraisal and modified Delphi method derived consensus statements regarding triggers for prompt patient assessment and initiating tMCS in CS, assessing adequacy of support, readiness for tMCS weaning, and next steps in nonrecovery. Individual statements were graded on the basis of the quality of available evidence.

Results: The panel addressed 4 main questions aimed at initiation, escalation, and de-escalation of tMCS. On the basis of available literature review and expert consensus, 11 recommendations were formulated. Key principles included recognition of the need for patients with CS who have ongoing hemodynamic compromise, tissue hypoperfusion, and metabolic derangements to be considered for early tMCS initiation. An interdisciplinary shock team should be involved in management, with early referral when patient conditions require care beyond center capabilities. Discussions providing anticipatory guidance should be performed with patients and decision makers before initiating tMCS. Management of tMCS involves frequent, timely hemodynamic and tissue perfusion reassessments to determine the need for escalation or weaning. For patients unable to be weaned from tMCS, evaluation should include interdisciplinary assessment for advanced therapies, with palliation included as a consideration in care discussions.

Conclusions: A practical guide to initiation, escalation, and de-escalation of tMCS is provided. Center-specific approaches that are based on local capabilities should be implemented.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2025.01.038DOI Listing

Publication Analysis

Top Keywords

escalation de-escalation
16
initiation escalation
12
de-escalation tmcs
12
tmcs
10
temporary mechanical
8
mechanical circulatory
8
circulatory support
8
initiating tmcs
8
escalation
5
de-escalation temporary
4

Similar Publications

Objectives: This study aimed to evaluate the prognostic value of metagenomic next-generation sequencing(mNGS) using Nanopore sequencing technology (NST) versus traditional culture methods in infectious disease cases.

Methods: We conducted a retrospective, single-center observational study comparing clinical outcomes between patients and specimen types in NST group and those in culture-based control group. Cox Proportional Hazards regression and Kaplan-Meier survival analysis were conducted to evaluate the association between diagnostic strategy and 28-day mortality.

View Article and Find Full Text PDF

Liquid biopsy, specifically circulating tumor DNA (ctDNA) analysis, has emerged as a transformative tool in precision oncology, providing real-time, minimally invasive characterizations of the tumor and tumor dynamics. While tissue biopsy is a critical tool for baseline diagnosis of malignancy, it is often limited by sampling constraints and an inability to capture tumor heterogeneity. In this study, we explored the clinical utility of serial ctDNA testing in guiding therapeutic decisions across a cohort of 30 patients with diverse solid tumors.

View Article and Find Full Text PDF

Evolving cystic fibrosis care models in the modulator era.

Curr Opin Pulm Med

September 2025

Departments of Medicine and Pediatrics, Medical University of South Carolina, Charleston, South Carolina, USA.

Purpose Of Review: The advent of CFTR modulators and the adoption of telemedicine during the COVID-19 pandemic have prompted reconsideration of cystic fibrosis (CF) care models. This review explores how care delivery may evolve in response to these changes.

Recent Findings: Emerging evidence highlights the heterogeneity in response to CFTR modulators, with some patients continuing to experience disease progression.

View Article and Find Full Text PDF